What are CareDx's total assets?

CareDx (CDNA) holds $411.1M in total assets, down 16.1% year over year.

How much debt does CareDx have?

CareDx carries $24.5M in total debt against $313.5M of shareholders' equity, a debt-to-equity ratio of 0.08.

How much cash does CareDx have?

CareDx holds $78.5M in cash and equivalents.

Can CareDx cover its short-term obligations?

Its current ratio is 3.40 — current assets exceed current liabilities.

Where does CareDx's balance sheet data come from?

Every line is extracted from CareDx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

CareDx CDNA Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$65.98M-42.8%	$115.27M+39.2%	$82.78M-8.5%	$90.44M-74.1%
Short-term investments	$111.78M-23.4%	$145.96M-4.7%	$153.22M-24.6%	$203.17M—
Restricted cash	$551K-5.8%	$585K-0.2%	$586K+12.3%	$522K+147%
Accounts receivable, net	$42.63M-34.0%	$64.61M+26.5%	$51.06M-23.0%	$66.31M+11.0%
Inventories	$26.71M+36.9%	$19.5M+0.2%	$19.47M+1.2%	$19.23M+11.9%
Raw materials	$13.16M+20.8%	$10.89M+2.5%	$10.62M-11.2%	$11.96M+14.5%
Work in process	$3.74M-1.4%	$3.79M-26.9%	$5.19M+20.6%	$4.31M+52.3%
Finished goods	$9.8M+103%	$4.82M+31.7%	$3.66M+23.5%	$2.96M-24.3%
Prepaid expenses and other current assets	$10.59M+49.8%	$7.07M-8.9%	$7.76M-15.8%	$9.22M+16.2%
Total current assets	$257.13M-26.9%	$351.83M+12.2%	$313.71M-19.1%	$387.85M-10.5%
Property and equipment, net	$32.97M-1.7%	$33.55M-4.8%	$35.25M-0.8%	$35.53M+61.2%
Accumulated depreciation	$46M+15.0%	$39.99M+18.9%	$33.64M+23.8%	$27.18M+27.5%
Operating lease right-of-use assets	7%-2,433,999,993%	2,434,000,000%-555,100,000%	2,989,100,000%-479,800,000%	3,468,900,000%+1,669,600,000%
Goodwill	$40.34M0.0%	$40.34M0.0%	$40.34M+7.5%	$37.52M+1.5%
Intangible assets, net	$28.47M-25.4%	$38.18M-16.4%	$45.7M+6.2%	$43.05M-14.2%
Other non-current assets	$3.35M+51.0%	$2.22M+64.2%	$1.35M-64.7%	$3.83M-34.4%
Total assets	$413.23M-15.8%	$491.05M+5.2%	$466.83M-14.0%	$542.99M-4.2%
Accrued expenses	$38.11M-0.6%	$38.33M+94.6%	$19.7M+16.6%	$16.9M-35.1%
Deferred revenue	$4.65M-4.0%	$4.85M+2.1%	$4.75M-11.1%	$5.34M+26.9%
Operating lease liabilities, current	$6.52M+6.8%	$6.1M+2.7%	$5.94M+6.3%	$5.59M+41.3%
Total current liabilities	$89.85M+0.5%	$89.37M+14.5%	$78.07M+2.8%	$75.98M-1.7%
Operating lease liabilities, non-current	$19.68M-11.6%	$22.26M-21.3%	$28.28M-15.4%	$33.41M+92.1%
Operating Lease Liabilities (Total)	$26.19M-7.7%	$28.37M-17.1%	$34.22M-12.2%	$39M+82.6%
Other non-current liabilities	$418K-35.2%	$645K-99.3%	$96.55M+38,676%	$249K-45.3%
Total liabilities	$1.78M-98.4%	$112.62M-45.2%	$205.5M+83.3%	$112.08M+11.3%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	100M+195,978%	51K+4.1%	49K-5.8%	52K0.0%
Additional paid-in capital	$1.04B+3.0%	$1.01B+7.0%	$946.51M+5.3%	$898.81M+5.3%
Retained earnings	-$735.36M-17.4%	-$626.24M+7.7%	-$678.27M-47.3%	-$460.44M-20.2%
Accumulated other comprehensive income (loss)	-$5.52M+35.6%	-$8.57M-23.1%	-$6.96M+7.2%	-$7.5M-60.7%
Total stockholders' equity	$303.1M-19.9%	$378.43M+44.8%	$261.33M-39.4%	$430.91M-7.5%
Total liabilities and stockholders' equity	$413.23M-15.8%	$491.05M+5.2%	$466.83M-14.0%	$542.99M-4.2%
Finished goods	$9.8M+103%	$4.82M+31.7%	$3.66M+23.5%	$2.96M-24.3%
Short- term Investments	$111.78M-23.4%	$145.96M-4.7%	$153.22M-24.6%	$203.17M—
Available-for-Sale Securities (Non-Current)	$24.17M—	——	——	——
Deferred Tax Assets and Other Non-Current Assets	$3.35M+51.0%	$2.22M+64.2%	$1.35M-64.7%	$3.83M-34.4%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——
Finite Lived Intangible Assets - Gross	$78.54M-1.7%	$79.88M0.0%	$79.88M+8.3%	$73.76M+0.9%
Indefinite-Lived Intangible Assets	$3.49M-0.4%	$3.51M-11.8%	$3.98M—	——
Indefinite-Lived Intangible Assets, Gross	$3.49M-0.4%	$3.51M-11.8%	$3.98M—	——
Indefinite-Lived Research and Development Assets	$3.49M-0.4%	$3.51M-11.8%	$3.98M—	——
Indefinite-Lived Trademarks	$3.49M-0.4%	$3.51M-11.8%	$3.98M—	——
Intangible Assets Gross (Excluding Goodwill)	$82.03M-1.6%	$83.39M-0.6%	$83.86M+11.8%	$75.01M+0.8%
Net Investment in Lease	$22.76M-6.5%	$24.34M-18.6%	$29.89M-13.8%	$34.69M+92.8%
Intangible assets — net	$28.47M-17.9%	$34.68M-16.9%	$41.73M-0.2%	$41.8M-14.6%
Other intangible assets—net	$31.96M-16.3%	$38.18M-16.4%	$45.7M+6.2%	$43.05M-14.2%
Long- term Investments	$24.17M—	$0—	——	——
Operating lease right-of-use assets	$22.76M-6.5%	$24.34M-18.6%	$29.89M-13.8%	$34.69M+92.8%
Other non-current assets	$3.35M+51.0%	$2.22M+64.2%	$1.35M-64.7%	$3.83M-34.4%
Property, plant and equipment, net	$32.97M-1.7%	$33.55M-4.8%	$35.25M-0.8%	$35.53M+61.2%
Operating Lease Right-of-Use Assets in Other Assets	$22.76M-6.5%	$24.34M-18.6%	$29.89M-13.8%	$34.69M+92.8%
Software and Technology Licenses, Net	$3.35M+51.0%	$2.22M+64.2%	$1.35M-64.7%	$3.83M-34.4%
Accrued Manufacturing Costs	$38.11M-0.6%	$38.33M+94.6%	$19.7M+16.6%	$16.9M-35.1%
Contract Liabilities and Refund Liability	$3.5M—	——	——	——
Compensation and benefits	$38.11M-0.6%	$38.33M+94.6%	$19.7M+16.6%	$16.9M-35.1%
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	——	——	——
Lease Liability Payments - Due Year Two	——	——	——	——
Lease Liability Payments - Due Year Three	——	——	——	——
Lease Liability Payments - Due Year Four	——	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	——	——	——
Operating Lease Liability Payments Due	——	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	——	——	——	——
Professional Service Fees Payable	$4.99M-16.5%	$5.97M+1.0%	$5.91M-3.3%	$6.12M+5.8%
Contingent Consideration Liability (Non-Current)	$161K-7.5%	$174K-92.9%	$2.46M—	——
Operating Lease Liability Payments - 2027 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	——	——	——
Accrued expenses and other liabilities	$41.75M-3.7%	$43.35M-4.7%	$45.5M-7.4%	$49.13M+29.6%
Total debt	$26.19M-7.7%	$28.37M-17.1%	$34.22M-12.2%	$39M+82.6%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	50.9M-7.0%	54.8M+6.3%	51.5M-3.9%	53.6M+1.2%
Convertible Preferred Stock Authorized Shares	10M0.0%	10M0.0%	10M0.0%	10M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—
Additional paid-in capital	$1.04B+3.0%	$1.01B+7.0%	$946.51M+5.3%	$898.81M+5.3%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$50K-2.0%	$51K+4.1%	$49K-5.8%	$52K0.0%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Number of Exercisable Options	——	——	——	——
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share-Based Payment Award Options Outstanding - Number	2.5M-27.3%	3.4M+11.6%	3.1M+4.6%	2.9M+56.8%
Shares Reserved for Future Issuance Under Stock Plans	10.1M-24.2%	13.4M—	——	1.5M-27.9%
Weighted Average Exercise Price of Outstanding Options	$20.47-9.5%	$22.63-10.2%	$25.21-10.4%	$28.13-4.1%
Clinical studies	$12.36M-23.6%	$16.17M+2.7%	$15.74M+6.3%	$14.82M+39.1%
Professional service fees	$4.99M-16.5%	$5.97M+1.0%	$5.91M-3.3%	$6.12M+5.8%
Common stock, capital shares reserved for future issuance	$10.14M-24.2%	$13.37M—	——	——
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$100M0.0%	$100M0.0%	$100M0.0%	$100M0.0%
Common stock, shares issued (in shares)	$50.92M-7.0%	$54.77M+6.3%	$51.5M-3.9%	$53.58M+1.2%
Common Stock, Shares, Outstanding	$50.92M-7.0%	$54.77M+6.3%	$51.5M-3.8%	$53.53M+1.2%
Number of votes entitled per share	——	——	——	——
Estimated rate refund liabilities	$3.5M—	——	——	——
Deferred income taxes	$181K+10.4%	$164K+20.6%	$136K—	$0-100%
Thereafter	——	——	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	$46M+15.0%	$39.99M+18.9%	$33.64M+23.8%	$27.18M+27.5%
2028	——	——	——	——
2030	——	——	——	——
Remainder of 2026	——	——	——	——
2027	——	——	——	——
2029	——	——	——	——
Finite Lived Intangible Assets, Foreign Currency Translation	$4.07M—	——	——	——
Gross Carrying Amount	$78.54M-1.7%	$79.88M0.0%	$79.88M+8.3%	$73.76M+0.9%
Trademarks	$3.49M-0.4%	$3.51M-11.8%	$3.98M—	——
Indefinite- lived intangible impairment	$82.03M-1.6%	$83.39M-0.6%	$83.86M+11.8%	$75.01M+0.8%
Lessee Operating Lease Liability Payments Due	——	——	——	——
Thereafter	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	——	——
Unrealized Holding Gains	$652K-72.5%	$2.37M—	——	——
Marketable Securities, Accumulated Unrecognized Holding Loss, Short Term	——	$4K—	——	——
Marketable Securities, Amortized Cost, Short Term	$135.94M-6.9%	$145.96M-4.7%	$153.22M-24.6%	$203.17M—
Fair Value	$136.6M-7.9%	$148.33M-4.9%	$155.97M-23.3%	$203.4M—
Operating Lease Weighted Average Discount Rate Percent	$0.07-1.4%	$0.070.0%	$0.070.0%	$0.07—
Other accrued liabilities	$9.74M+37.6%	$7.08M+154%	$2.79M-38.8%	$4.55M+91.7%
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$2.48M-27.3%	$3.41M+11.6%	$3.06M+4.6%	$2.92M+56.8%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$20.47-9.5%	$22.63-10.2%	$25.21-10.4%	$28.13-4.1%
Incentive stock program, shares reserved for future grants (in shares)	——	$4.56M+425%	$869.11K-41.7%	$1.49M-27.9%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	——	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——
Remainder of Fiscal Year 2025	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about CareDx.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are CareDx's total assets?: CareDx (CDNA) holds $411.1M in total assets, down 16.1% year over year.
How much debt does CareDx have?: CareDx carries $24.5M in total debt against $313.5M of shareholders' equity, a debt-to-equity ratio of 0.08.
How much cash does CareDx have?: CareDx holds $78.5M in cash and equivalents.
Can CareDx cover its short-term obligations?: Its current ratio is 3.40 — current assets exceed current liabilities.
Where does CareDx's balance sheet data come from?: Every line is extracted from CareDx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.